APA (7th ed.) Citation
(2026). Clinical Remission in Severe T2‐High Asthma in Real Life After Anti‐IgE, Anti‐IL‐5 and Anti‐IL5R: A Potential Role for CRP as a Biomarker. Clinical and Translational Allergy.
Chicago Style (17th ed.) Citation
"Clinical Remission in Severe T2‐High Asthma in Real Life After Anti‐IgE, Anti‐IL‐5 and Anti‐IL5R: A Potential Role for CRP as a Biomarker." Clinical and Translational Allergy 2026.
MLA (9th ed.) Citation
"Clinical Remission in Severe T2‐High Asthma in Real Life After Anti‐IgE, Anti‐IL‐5 and Anti‐IL5R: A Potential Role for CRP as a Biomarker." Clinical and Translational Allergy, 2026.
Warning: These citations may not always be 100% accurate.